Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Medina, Jorge L ^a,b   Coalson, Jacqueline J ^a   Brooks, Edward G ^b   Le Saux, Claude Jourdan ^b   Winter, Vicki T ^a   Chaparro, Adriana ^b   Principe, Molly F R ^b   Solis, Laura ^b   Kannan, T R ^a,b   Baseman, Joel B ^a,b   Dube, Peter H ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CHEMOKINE; COMMUNITY ACQUIRED RESPIRATORY DISTRESS SYNDROME TOXIN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; MACROPHAGE DERIVED CHEMOKINE; OVALBUMIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CARDS TOXIN, MYCOPLASMA PNEUMONIAE; CCL17 PROTEIN, MOUSE; CCL22 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

AIRWAY HYPERREACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE EXACERBATION; EOSINOPHIL; HISTOLOGY; INFLAMMATION; LUNG FUNCTION; MOUSE; MYCOPLASMA PNEUMONIAE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; RISK FACTOR; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BRONCHUS HYPERREACTIVITY; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HUMAN; IMMUNOLOGY; LUNG LAVAGE; PATHOLOGY; RESPIRATORY SYSTEM;

ANIMALS; ASTHMA; BACTERIAL PROTEINS; BACTERIAL TOXINS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL17; CHEMOKINE CCL22; EOSINOPHILS; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; OVALBUMIN; RECOMBINANT PROTEINS; RESPIRATORY SYSTEM; TH2 CELLS;

EID: 84904814170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102613     Document Type: Article

References (45)

1. Lemanske RF Jr, Busse WW (2010) Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 125: S95-102.
2. Blasi F (2004) Atypical pathogens and respiratory tract infections. Eur Respir J 24: 171-181.
3. Johnston SL, Martin RJ (2005) Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 172: 1078-1089. (Pubitemid 43066642)
4. Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, et al. (1998) Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 158: 998-1001. (Pubitemid 28449473)
5. Kraft M, Cassell GH, Pak J, Martin RJ (2002) Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121: 1782-1788. (Pubitemid 34634396)
6. Lieberman D, Printz S, Ben-Yaakov M, Lazarovich Z, Ohana B, et al. (2003) Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 167: 406-410. (Pubitemid 36216424)
7. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH (2001) A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107: 595-601. (Pubitemid 32397743)
8. Seggev JS, Lis I, Siman-Tov R, Gutman R, Abu-Samara H, et al. (1986) Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann Allergy 57: 263-265. (Pubitemid 16008807)
9. Waites KB, Talkington DF (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17: 697-728, table of contents. (Pubitemid 39372513)
10. Atkinson TP, Balish MF, Waites KB (2008) Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS microbiology reviews 32: 956-973.
11. Hardy RD, Jafri HS, Olsen K, Hatfield J, Iglehart J, et al. (2002) Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect Immun 70: 649-654. (Pubitemid 34083823)
12. Martin RJ, Chu HW, Honour JM, Harbeck RJ (2001) Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 24: 577-582. (Pubitemid 32442765)
13. Sutherland ER, Martin RJ (2007) Asthma and atypical bacterial infection. Chest 132: 1962-1966.
14. Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, et al. (2011) Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma. Chest 140: 401-407.
15. Wood PR, Hill VL, Burks ML, Peters JI, Singh H, et al. (2013) Mycoplasma pneumoniae in children with acute and refractory asthma. Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology 110: 328-334 e321.
16. Fonseca-Aten M, Rios AM, Mejias A, Chavez-Bueno S, Katz K, et al. (2005) Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. Am J Respir Cell Mol Biol 32: 201-210. (Pubitemid 40387646)
17. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ (2003) Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 71: 1520-1526. (Pubitemid 36254340)
18. Wu Q, Martin RJ, LaFasto S, Chu HW (2009) A low dose of Mycoplasma pneumoniae infection enhances an established allergic inflammation in mice: the role of the prostaglandin E2 pathway. Clin Exp Allergy 39: 1754-1763.
19. Hardy RD, Coalson JJ, Peters J, Chaparro A, Techasaensiri C, et al. (2009) Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One 4: e7562.
20. Kannan TR, Baseman JB (2006) ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A 103: 6724-6729.
21. Kannan TR, Provenzano D, Wright JR, Baseman JB (2005) Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun 73: 2828-2834. (Pubitemid 40570350)
22. Medina JL, Coalson JJ, Brooks EG, Winter VT, Chaparro A, et al. (2012) Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol 46: 815-822.
23. Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, et al. (2008) Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 9: 48.
24. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, et al. (2004) Mycoplasma pneumoniae and asthma in children. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 38: 1341-1346.
25. Kraft M, Adler KB, Ingram JL, Crews AL, Atkinson TP, et al. (2008) Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. The European respiratory journal 31: 43-46.
26. Wu Q, Martin RJ, Lafasto S, Efaw BJ, Rino JG, et al. (2008) Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. American journal of respiratory and critical care medicine 177: 720-729. (Pubitemid 351490559)
27. Bubeck SS, Cantwell AM, Dube PH (2007) Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun 75: 697-705. (Pubitemid 46203431)
28. Bell RE, Kuehl TJ, Coalson JJ, Ackerman NB Jr, Null DM Jr, et al. (1984) High-frequency ventilation compared to conventional positive-pressure ventilation in the treatment of hyaline membrane disease in primates. Crit Care Med 12: 764-768. (Pubitemid 14041824)
29. Delemos RA, Coalson JJ, Gerstmann DR, Null DM Jr, Ackerman NB, et al. (1987) Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Pediatr Res 21: 594-602. (Pubitemid 17076194)
30. Rucker G, Schimek-Jasch T, Nestle U (2012) Measuring inter-observer agreement in contour delineation of medical imaging in a dummy run using Fleiss' kappa. Methods of information in medicine 51: 489-494.
31. Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychological Bulletin 76: 378-382.
32. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez AC, et al. (1996) Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. The Journal of clinical investigation 98: 2332-2345. (Pubitemid 26394208)
33. Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, et al. (2005) Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J Biol Chem 280: 13952-13961. (Pubitemid 40517296)
34. Kumar RK, Foster PS (2002) Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 27: 267-272. (Pubitemid 34979284)
35. Tomkinson A, Duez C, Cieslewicz G, Pratt JC, Joetham A, et al. (2001) A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J Immunol 166: 5792-5800. (Pubitemid 32374206)
36. Jacobsen EA, Ochkur SI, Pero RS, Taranova AG, Protheroe CA, et al. (2008) Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J Exp Med 205: 699-710. (Pubitemid 351439314)
37. Johnson C, Kannan TR, Baseman JB (2011) Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments. PLoS One 6: e22877.
38. Kannan TR, Musatovova O, Balasubramanian S, Cagle M, Jordan JL, et al. (2010) Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol Microbiol 76: 1127-1141.
39. Chu HW, Rino JG, Wexler RB, Campbell K, Harbeck RJ, et al. (2005) Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol 289: L125-133. (Pubitemid 40863562)
40. Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, et al. (2010) Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains. Am J Respir Crit Care Med 182: 797-804.
41. Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nature reviews Immunology 13: 9-22.
42. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, et al. (2009) Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. The New England journal of medicine 360: 985-993.
43. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, et al. (2009) Mepolizumab and exacerbations of refractory eosinophilic asthma. The New England journal of medicine 360: 973-984.
44. Rose CE Jr, Lannigan JA, Kim P, Lee JJ, Fu SM, et al. (2010) Murine lung eosinophil activation and chemokine production in allergic airway inflammation. Cellular & molecular immunology 7: 361-374.
45. Wenzel SE, Vitari CA, Shende M, Strollo DC, Larkin A, et al. (2012) Asthmatic granulomatosis: a novel disease with asthmatic and granulomatous features. American journal of respiratory and critical care medicine 186: 501-507.